TURTLE CAMERON (Chief Executive Officer) sold 2.2% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $460.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/6/2026ACC: 0001758363-26-000002
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$460.1K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−12.71K
Price / share
$30.47
Trade value
$387.24K
% of position
1.9%
1/2/2026
686.91K→674.20K
Common Stock
Direct
Shares
−2.19K
Price / share
$31.79
Trade value
$69.65K
% of position
0.3%
1/2/2026
674.20K→672.01K
Common Stock
Direct
Shares
−100.00
Price / share
$32.39
Trade value
$3.24K
% of position
0.0%
1/2/2026
672.01K→671.91K
Total
Net shares
−15K
Net value
-$460.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −12.71K | $30.47 | $387.24K | 1.9% | 686.91K | 674.20K |
| Common Stock Direct | 1/2/2026 | S · Sale | −2.19K | $31.79 | $69.65K | 0.3% | 674.20K | 672.01K |
| Common Stock Direct | 1/2/2026 | S · Sale | −100.00 | $32.39 | $3.24K | 0.0% | 672.01K | 671.91K |
| Total | −15K | -$460.13K | ||||||
Derivative Transactions0
No derivative transactions reported